Try our beta test site

Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2017 by UNC Lineberger Comprehensive Cancer Center
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01578954
First received: April 13, 2012
Last updated: February 17, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2019
  Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)